immunization schedule

Summary

Summary: Schedule giving optimum times usually for primary and/or secondary immunization.

Top Publications

  1. ncbi A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults
    Eric E Mast
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention proposed, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-33; quiz CE1-4. 2006
  2. ncbi The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule
    Martin O Ota
    Medical Research Council Laboratories, Banjul, Gambia
    Vaccine 29:2999-3007. 2011
  3. ncbi Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data
    Andrew Clark
    Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
    Lancet 373:1543-9. 2009
  4. ncbi Epidemiology of pertussis
    Tina Tan
    Feinberg School of Medicine, Division of Infectious Disease, Children s Memorial Hospital, 2300 Children s Plaza, Box 20, Chicago, IL 60614 3394, USA
    Pediatr Infect Dis J 24:S10-8. 2005
  5. ncbi Validity of reported vaccination coverage in 45 countries
    Christopher J L Murray
    Department of Health Service Provision, Evidence and Information for Policy, WHO, 27 Geneva, Switzerland
    Lancet 362:1022-7. 2003
  6. ncbi Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
    F T Cutts
    Medical Research Council Laboratories, Banjul, The Gambia
    Lancet 365:1139-46. 2005
  7. pmc Accelerating control of pertussis in England and Wales
    Helen Campbell
    Health Protection Agency, London, UK
    Emerg Infect Dis 18:38-47. 2012
  8. ncbi Immunogenicity of a three-component acellular pertussis vaccine administered at birth
    Cesare Belloni
    Division of Neonatology and Neonatal Intensive Care, IRCCS Policlinico San Matteo Pavia, Italy
    Pediatrics 111:1042-5. 2003
  9. pmc Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
    F M Russell
    Centre for International Child Health, Department of Paediatrics, University of Melbourne, Royal Children s Hospital, Melbourne, Australia
    Vaccine 28:3086-94. 2010
  10. ncbi Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States
    Hayley A Gans
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305 5208, USA
    J Infect Dis 190:83-90. 2004

Detail Information

Publications282 found, 100 shown here

  1. ncbi A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults
    Eric E Mast
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention proposed, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-33; quiz CE1-4. 2006
    ....
  2. ncbi The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule
    Martin O Ota
    Medical Research Council Laboratories, Banjul, Gambia
    Vaccine 29:2999-3007. 2011
    ....
  3. ncbi Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data
    Andrew Clark
    Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
    Lancet 373:1543-9. 2009
    ..We estimated vaccination coverage at different ages, and delays in administration, in 45 low-income and middle-income countries...
  4. ncbi Epidemiology of pertussis
    Tina Tan
    Feinberg School of Medicine, Division of Infectious Disease, Children s Memorial Hospital, 2300 Children s Plaza, Box 20, Chicago, IL 60614 3394, USA
    Pediatr Infect Dis J 24:S10-8. 2005
    ..Understanding the link between these observations may lead to better informed global control strategies, especially those pertaining to immunization schedules and use of pertussis vaccine...
  5. ncbi Validity of reported vaccination coverage in 45 countries
    Christopher J L Murray
    Department of Health Service Provision, Evidence and Information for Policy, WHO, 27 Geneva, Switzerland
    Lancet 362:1022-7. 2003
    ..We aimed to assess the accuracy of officially reported coverage rates of vaccination with diphtheria-tetanus-pertussis vaccine (DTP3), which is commonly used to monitor child health interventions...
  6. ncbi Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
    F T Cutts
    Medical Research Council Laboratories, Banjul, The Gambia
    Lancet 365:1139-46. 2005
    ..Pneumonia is estimated to cause 2 million deaths every year in children. Streptococcus pneumoniae is the most important cause of severe pneumonia. We aimed to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children...
  7. pmc Accelerating control of pertussis in England and Wales
    Helen Campbell
    Health Protection Agency, London, UK
    Emerg Infect Dis 18:38-47. 2012
    ..e., <3 months of age), teenagers, and adults. Future vaccine program changes may be beneficial, but additional detail is required to inform such decisions...
  8. ncbi Immunogenicity of a three-component acellular pertussis vaccine administered at birth
    Cesare Belloni
    Division of Neonatology and Neonatal Intensive Care, IRCCS Policlinico San Matteo Pavia, Italy
    Pediatrics 111:1042-5. 2003
    ..Furthermore, we investigated the influence of maternal antibodies on aP vaccine response...
  9. pmc Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
    F M Russell
    Centre for International Child Health, Department of Paediatrics, University of Melbourne, Royal Children s Hospital, Melbourne, Australia
    Vaccine 28:3086-94. 2010
    ..By 17 months the PPV-23 group still had significantly higher GMC (each p<0.001) for all serotypes. The PPV-23 was well tolerated and induced excellent responses for all serotypes which were greatest in the single PCV-7 group...
  10. ncbi Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States
    Hayley A Gans
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305 5208, USA
    J Infect Dis 190:83-90. 2004
    ..Shifts in peak measles incidence to children <12 months old and the associated high mortality support the study of an early 2-dose measles vaccine regimen...
  11. ncbi Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children
    Arunee Sabchareon
    Vaccine Trial Center, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Pediatr Infect Dis J 23:99-109. 2004
    ..The safety and immunogenicity of tetravalent live-attenuated dengue vaccines after a three dose vaccination series were evaluated in Thai children...
  12. pmc Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom
    Ray Borrow
    PHLS Meningococcal Reference Unit, Withington Hospital, Manchester, United Kingdom
    Infect Immun 71:5549-55. 2003
    ..This study provides the first evidence that the number of doses of MCC-TT used in infant immunization schedules could be decreased...
  13. ncbi A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents
    Eric E Mast
    Division of Viral Hepatitis, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 54:1-31. 2005
    ..The second part of the ACIP statement, which will include updated recommendations and strategies to increase hepatitis B vaccination of adults, will be published separately...
  14. ncbi Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
    Sorachai Nitayaphan
    Royal Thai Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
    J Infect Dis 190:702-6. 2004
    ..This vaccine combination was well tolerated and was immunogenic, meeting milestones for advancement to phase 3 evaluation...
  15. ncbi Early Impact of the US Tdap vaccination program on pertussis trends
    Tami H Skoff
    Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop C 25, Atlanta, GA 30333, USA
    Arch Pediatr Adolesc Med 166:344-9. 2012
    ..To evaluate the impact of the adolescent Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine) vaccination program on pertussis trends in the United States...
  16. ncbi Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults
    D V Potsch
    HUCFF FM Universidade Federal do Rio de Janeiro, Brazil
    Vaccine 30:5973-7. 2012
    ..Antibody responses to standard regimens of hepatitis B (HBV) vaccination are lower in HIV-infected subjects and the best hepatitis B vaccine schedule in this population is not known...
  17. ncbi Assessment of varicella vaccine effectiveness in Germany: a time-series approach
    M Hohle
    Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
    Epidemiol Infect 139:1710-9. 2011
    ....
  18. ncbi Knowledge of the childhood immunization schedule and of contraindications to vaccinate by private and public providers in Los Angeles
    D Wood
    RAND, Santa Monica, CA, USA
    Pediatr Infect Dis J 15:140-5. 1996
    Missed opportunities to vaccinate occur commonly and contribute to the underimmunization of young children. They are related to provider knowledge of the immunization schedule and contraindications to vaccination.
  19. ncbi Current issues with the immunization program in Japan: can we fill the "vaccine gap"?
    Akihiko Saitoh
    Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Chuo Ku, Niigata 951 8510, Japan
    Vaccine 30:4752-6. 2012
    ....
  20. pmc Vaccination coverage and timeliness in three South African areas: a prospective study
    Lars T Fadnes
    Centre for International Health, University of Bergen, Norway
    BMC Public Health 11:404. 2011
    ..Timely vaccination is important to induce adequate protective immunity. We measured vaccination timeliness and vaccination coverage in three geographical areas in South Africa...
  21. ncbi Alternative vaccination schedule preferences among parents of young children
    Amanda F Dempsey
    Child Health Evaluation and Research Unit, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109 5456, USA
    Pediatrics 128:848-56. 2011
    ..We sought to describe national patterns of alternative vaccination schedule use and the potential "malleability" of parents' current vaccination schedule choices...
  22. pmc Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study
    Juliet N Babirye
    School of Public Health, Makerere University College of Health Sciences, Kampala Uganda
    PLoS ONE 7:e35432. 2012
    ..In addition to examining timeliness of the recommended Expanded Programme for Immunisation (EPI) vaccines, this paper identifies predictors of untimely vaccination among children aged 10 to 23 months in Kampala...
  23. ncbi Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda
    Lars T Fadnes
    Centre for International Health, University of Bergen, 5018 Bergen, Norway
    Vaccine 29:3564-70. 2011
    ..Timely vaccination is important to protect children from common infectious diseases. We assessed vaccination timeliness and vaccination coverage as well as coverage of vitamin A supplementation in a Ugandan setting...
  24. ncbi Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany
    Dorothee M Kieninger
    Arztin für Kinder und Jugendmedizin, Zentrum für Kinder und Jugendmedizin der Universitätsmedizin der Johannes Gutenberg Universität Mainz KOR, Mainz, Germany
    Vaccine 28:4192-203. 2010
    ..Vaccines were comparable with regard to safety. PCV13 should be as effective as PCV7 in preventing pneumococcal disease caused by the common serotypes and may provide protection against the additional serotypes...
  25. ncbi Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs
    Peter Aaby
    Bandim Health Project, Apartado 861, Bissau, Guinea Bissau
    Int J Epidemiol 33:367-73. 2004
    ..As background information, we examined sex- and age-specific mortality patterns in the pre-vaccination era. Subjects In all, 626 female-male twin pairs identified between 1978 and 2000...
  26. ncbi Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
    Sander Van Assen
    Department of Internal Medicine, Division of Infectious Diseases, University Medical Center Groningen, Groningen, The Netherlands
    Arthritis Rheum 62:75-81. 2010
    ..We also undertook to assess the safety of influenza vaccination and the effects of previous influenza vaccination...
  27. ncbi General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)
    William L Atkinson
    Immunization Services Division, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 51:1-35. 2002
    ..This report, ACIP recommendations for each vaccine, and other information regarding immunization can be accessed at CDCs National Immunization Program website at http.//www.cdc.gov/nip (accessed October 11, 2001)...
  28. pmc Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable?
    Jennifer C Moïsi
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Vaccine 28:5725-30. 2010
    ..Travel time did not affect vaccination coverage or timeliness. The Kenyan EPI reaches nearly all children in Kilifi and delays in vaccination are few, suggesting that vaccines will have maximal impact on child morbidity and mortality...
  29. ncbi Timeliness of childhood immunizations
    Elizabeth T Luman
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 110:935-9. 2002
    ..To examine the timeliness of vaccine administration among infants and young children in the United States...
  30. ncbi Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
    Anthony E Fiore
    Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
    MMWR Recomm Rep 58:1-52. 2009
    ..Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information...
  31. ncbi Factors influencing immunisation coverage in Mathare Valley, Nairobi
    L O Owino
    Ministry of Health, Kisii District Hospital, P O Box 92, Kisii, Kenya
    East Afr Med J 86:323-9. 2009
    ..To determine the factors that influence immunisation coverage...
  32. ncbi Timeliness of childhood immunisation in Australia
    Brynley P Hull
    National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead and the University of Sydney, NSW, Australia
    Vaccine 24:4403-8. 2006
    ....
  33. ncbi Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
    Caroline L Trotter
    Statistics, Economics, and Modelling Department, Health Protection Agency Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK
    Lancet 364:365-7. 2004
    ..The number of individuals in these cohorts remains low, but alternative routine immunisation schedules should be considered to ensure high levels of protection are sustained...
  34. ncbi Hepatitis B and the need for a booster dose
    Elke Leuridan
    Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, Faculty of Medicine, University of Antwerp, Edegem, Belgium
    Clin Infect Dis 53:68-75. 2011
    ..However, a booster dose should be planned for immunocompromised patients, based on serological monitoring...
  35. ncbi Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial
    Terry Nolan
    Vaccine and Immunization Research Group, School of Population Health, University of Melbourne, and Murdoch Children s Research Institute, Victoria, Australia
    JAMA 303:37-46. 2010
    ..In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children...
  36. ncbi Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial
    Roly D Gosling
    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Lancet 374:1521-32. 2009
    ..However, rising resistance to this combination is a concern. We investigated a shortacting and longacting antimalarial drug as alternative regimens for IPTi...
  37. ncbi Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed
    Elizabeth T Luman
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 293:1204-11. 2005
    ..Only 18% of children in the United States receive all vaccinations at the recommended times or acceptably early...
  38. pmc Detection of delayed vaccinations: a new approach to visualize vaccine uptake
    B Laubereau
    Department of Paediatric and Adolescent Epidemiology, Institute for Social Paediatrics and Adolescent Medicine, Ludwig Maximilians University, Munchen, Germany
    Epidemiol Infect 128:185-92. 2002
    ..0 and 24.3 months. These estimates were only possible with the KM method which proved useful to monitor vaccination programmes and will allow the comparison of vaccination uptake in different populations...
  39. ncbi Immunisation coverage in Australian Indigenous children: Time to move the goal posts
    Kerry Ann O'Grady
    School of Population Health and Department of Paediatrics, University of Melbourne, Victoria, Australia
    Vaccine 27:307-12. 2009
    ..5% and 81.2% at 13 and 18 months of age, respectively. Immunisation performance benchmarks must focus on improving the timeliness in these children in the first year of life...
  40. ncbi Systematic review of the effects of pertussis vaccines in children
    Tom Jefferson
    Health Reviews Ltd, Via Adige 28a, 00061 Anguillara Sabazia, Rome, Italy
    Vaccine 21:2003-14. 2003
    ..To assess the efficacy and safety of whole-cell and acellular pertussis vaccines administered to children singly or within diphtheria, tetanus and pertussis (DTP) vaccines...
  41. pmc Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies
    L Coudeville
    Sanofi Pasteur, Lyon, France
    Epidemiol Infect 136:604-20. 2008
    ..The model also predicts that the optimal age for this booster dose is 40 years. These results support the 2006 American Academy of Immunization Practices' recommendations for adolescent and adult vaccination against pertussis...
  42. ncbi Benefits of routine immunizations on childhood survival in Tari, Southern Highlands Province, Papua New Guinea
    Deborah Lehmann
    Papua New Guinea Institute of Medical Research, Goroka and Tari, Papua New Guinea
    Int J Epidemiol 34:138-48. 2005
    ..This study aimed to determine the effects of diphtheria-tetanus-whole-cell-pertussis (DTP), BCG, hepatitis B, and measles vaccines on mortality in the highlands of Papua New Guinea (PNG)...
  43. pmc Immunization status of children admitted to a tertiary-care hospital of north India: reasons for partial immunization or non-immunization
    Devendra Kumar
    Department of Pediatrics, University College of Medical Science and Guru Teg Bahadur Hospital, Delhi 110 095, India
    J Health Popul Nutr 28:300-4. 2010
    ..The immunization status needs to be improved by education, increasing awareness, and counselling of parents and caregivers regarding immunizations and associated misconceptions as observed in the study...
  44. ncbi Benefits of early hepatitis B immunization programs for newborns and infants
    Koen Van Herck
    WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Vaccine, and Infectious Disease Institute, University of Antwerp, Belgium
    Pediatr Infect Dis J 27:861-9. 2008
    ....
  45. ncbi Scheduling of measles vaccination in low-income countries: projections of a dynamic model
    C T Bauch
    Department of Mathematics and Statistics, University of Guelph, Guelph, ON N1G 2W1, Canada
    Vaccine 27:4090-8. 2009
    ..If RI remains stagnant, India and Nigeria should hold SIAs every 2 years, and the other countries every 4-6 years...
  46. ncbi Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study
    Stephanie R Bialek
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatr Infect Dis J 27:881-5. 2008
    ..Long-term follow-up studies of populations that received recombinant hepatitis B (HB) vaccination beginning at birth are limited...
  47. ncbi Adult immunization: what can we learn from the childhood immunization program?
    Alan R Hinman
    Clin Infect Dis 44:1532-5. 2007
  48. ncbi Improving influenza vaccination rates for children through year-round scheduling
    Ian M Paul
    Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
    Ambul Pediatr 6:230-4. 2006
    ....
  49. ncbi Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21)
    Ines Schoendorf
    Novartis Vaccines and Diagnostics, GmbH and Co KG, Marburg, Hessen 35041, Germany
    Hum Vaccin 3:42-7. 2007
    ..On Day 300, GMC ELISA of Group R was higher compared to Group C and Group M. To conclude, the rapid immunization schedule in children not only provides fast protection but also leads to stable titers as measured by NT for at ..
  50. ncbi Patient adherence to three dose completion of the quadrivalent human papillomavirus (HPV) vaccine in a private practice
    Rochelle F Rubin
    Dreyer Medical Clinic, Midwestern University, Downers Grove, IL 60515, USA
    J Community Health 37:1145-50. 2012
    ....
  51. ncbi Varicella vaccination in Japan: necessity of implementing a routine vaccination program
    Takao Ozaki
    Department of Pediatrics, Konan Kosei Hospital, 137 Ohmatsubara, Takaya cho, Konan, Aichi, Japan
    J Infect Chemother 19:188-95. 2013
    ..To achieve this goal, implementation of a routine vaccination program for varicella and introduction of a two-dose vaccination schedule, which is more effective than a single-dose schedule, would be highly desirable...
  52. ncbi Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine
    M L Garly
    Projecto de Saude de Bandim, Apartado 861, 1004, Bissau Codex, Guinea Bissau
    Vaccine 19:1951-9. 2001
    ..The EZ vaccine was less sensitive to maternal antibodies, and able to increase the antibody response by revaccination, while the second SW vaccine resulted in an unchanged or lower antibody response...
  53. ncbi Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon
    Rachel Gold
    Kaiser Permanente Northwest Center for Health Research, Portland, OR 97227, USA
    Prev Med 52:456-8. 2011
    ..Given the challenges of administering a multi-dose vaccine to adolescents, especially those in vulnerable populations, we evaluated completion of the human papillomavirus vaccine series in 19 of Oregon's school-based health centers...
  54. pmc Assessing immunization data quality from routine reports in Mozambique
    João C Mavimbe
    Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
    BMC Public Health 5:108. 2005
    ..The present article, discusses the practices on record keeping, reporting and the support mechanism to ensure data quality in Mozambique...
  55. pmc Timeliness and completion rate of immunization among Nigerian children attending a clinic-based immunization service
    Ayebo E Sadoh
    Institute of Child Health, University of Benin, PMB 1154, Benin City, Edo State, Nigeria
    J Health Popul Nutr 27:391-5. 2009
    ..Only 227 (44.3%) children were fully immunized. Health education and mass mobilization of the community and health workers are recommended to improve the uptake of vaccines and to encourage timely receipt of vaccines...
  56. ncbi Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain
    Paul M Mendelman
    MedImmune Vaccines, Mountain View, CA, USA
    Pediatr Infect Dis J 23:1053-5. 2004
    ..Results indicated that the live vaccine induced higher antibody responses than the inactivated vaccine against the A/Panama and A/Fujian-like viruses...
  57. ncbi Factors influencing parental decision making when parents choose to deviate from the standard pediatric immunization schedule
    Maria D Whyte
    Valdosta State University, Valdosta, Georgia, USA
    J Community Health Nurs 28:204-14. 2011
    The purpose of this article is to present the results of a study focusing on the basis for parental decisions to refrain from the standard pediatric immunization schedule.
  58. pmc Antigenic diversity in Eimeria maxima and the influence of host genetics and immunization schedule on cross-protective immunity
    Adrian L Smith
    Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berks RG20 7NN, United Kingdom
    Infect Immun 70:2472-9. 2002
    ..These results are discussed in relation to the number of protective antigens presented by complex pathogens and the development of immunoprotective responses in hosts of different genetic backgrounds...
  59. pmc Effectiveness of individually tailored calendars in promoting childhood immunization in urban public health centers
    Matthew W Kreuter
    Health Communication Research Laboratory, Division of Behavioral Science and Health Education, Department of Community Health, School of Public Health, Saint Louis University, St Louis, MO 63104, USA
    Am J Public Health 94:122-7. 2004
    ..We examined the effectiveness of tailored calendars in increasing childhood immunization rates...
  60. ncbi Differences in vaccinations in European Union
    Susanna Esposito
    Institute of Pediatrics, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy
    Hum Vaccin 4:313-5. 2008
    ....
  61. ncbi Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America
    Larry K Pickering
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 49:817-40. 2009
    ..50 years, and a second dose of varicella vaccine has been added to the routine childhood and adolescent immunization schedule. Many of these changes have resulted in expansion of the adolescent and adult immunization schedules...
  62. ncbi Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation
    Philippe De Wals
    Faculty of Medicine, Laval University, and Quebec National Institute of Public Health, Canada
    Vaccine 24:3500-4. 2006
    ..Results showed that the efficacy of any immunization schedule was highly influenced by the rate at which immunity waned and that the benefit of a booster dose increased ..
  63. ncbi Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries
    Sean P Fitzwater
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
    Hum Vaccin 6:810-8. 2010
    ..Here, we present a synthesis of data supporting various Hib vaccine schedules, with a focus on the implications for developing countries...
  64. ncbi Childhood vaccination schedules in Europe vary widely. Is this a problem?
    P L Lopalco
    European Centre for Disease Prevention and Control, 171 83, Stockholm, Sweden
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52:1095-8. 2009
    ..National sovereignty in the area of vaccination programmes prevails; therefore any step forward will be feasible only if consensus in Europe is reached...
  65. ncbi Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Mona Marin
    Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
    MMWR Recomm Rep 59:1-12. 2010
    ..cdc.gov/vaccines/recs/provisional/downloads/combo-vax-Aug2009-508.pdf), which state that use of a combination vaccine generally is preferred over its equivalent component vaccines...
  66. pmc Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity?
    Neil Z Miller
    Think Twice Global Vaccine Institute, USA corrected
    Hum Exp Toxicol 30:1420-8. 2011
    ..The US childhood immunization schedule specifies 26 vaccine doses for infants aged less than 1 year--the most in the world--yet 33 nations have ..
  67. ncbi The impact of computer-generated messages on childhood immunization coverage
    E F Dini
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Am J Prev Med 18:132-9. 2000
    ..This study assesses the sustained impact of computer-generated messages on immunization coverage during the first two years of life...
  68. ncbi Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children
    M E Pichichero
    Department of Microbiology, University of Rochester School of Medicine, Rochester, New York, USA
    Pediatrics 105:e11. 2000
    ....
  69. pmc Effectiveness of measles vaccination and vitamin A treatment
    Christopher R Sudfeld
    Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, MD 21205, USA
    Int J Epidemiol 39:i48-55. 2010
    ....
  70. ncbi Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response
    María Victoria Lavigne
    Instituto de Estudios de la Inmunidad Humoral CONICET UBA, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junín 956 Piso 4, 1113 Buenos Aires, Argentina
    Microbes Infect 6:481-4. 2004
    ..is not necessary for protection against tetanus and therefore should be avoided, an alternative DTP immunization schedule with minimal Pw exposure was assessed in order to obtain a Th2 tetanus response and a Th1 pertussis ..
  71. ncbi Infant pertussis: who was the source?
    Kristine M Bisgard
    Bacterial Vaccine Preventable Diseases Branch, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 23:985-9. 2004
    ..In the United States in the 1990s, the incidence of reported pertussis in adults, adolescents and infants increased; infants younger than 1 year of age had the highest reported incidence...
  72. ncbi Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina
    G Fabricius
    Instituto de Investigaciones Fisicoquimicas Teoricas y Aplicadas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina
    Epidemiol Infect 141:718-34. 2013
    ..An effort to improve the coverage of the first dose would have a much greater impact on infants. These results hold in the 18 scenarios considered, which demonstrates the robustness of these conclusions...
  73. ncbi Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controll
    Menno R van den Bergh
    Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children s Hospital, University Medical Center Utrecht, The Netherlands
    Pediatr Infect Dis J 30:e170-8. 2011
    ..Recent reviews have highlighted the unpredictability of immunologic interference when multivalent conjugated vaccines are coadministered with other pediatric vaccines...
  74. ncbi Protecting infants against measles in England and Wales: a review
    G Manikkavasagan
    HPA Centre for Infections, London NW9 5EQ, UK
    Arch Dis Child 94:681-5. 2009
    ..To establish the most appropriate age ranges for the use of human normal immunoglobulin and MMR vaccine as postexposure prophylaxis...
  75. ncbi Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
    Suzanne L Epstein
    Laboratory of Immunology and Developmental Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Bethesda, MD 20852, USA
    Vaccine 23:5404-10. 2005
    ..Thus, gene-based vaccination with NP may contribute to protective immunity against diverse influenza viruses through its ability to stimulate cellular immunity...
  76. ncbi Evaluation of non-specific effects of infant immunizations on early infant mortality in a southern Indian population
    Lawrence H Moulton
    Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    Trop Med Int Health 10:947-55. 2005
    ..The aim of this study was to assess the relationship between receipt of routine childhood immunizations and infant mortality before 6 months of age...
  77. ncbi Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B
    Gillian M Keating
    Adis International Limited, Auckland, New Zealand
    Drugs 63:1021-51. 2003
    ..In addition, it appears that Hep-B(Eng) confers immunity for at least 10 years. Hep-B(Eng) has an important role in mass vaccination campaigns against hepatitis B, as well as in groups considered at high risk of acquiring hepatitis B...
  78. ncbi Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up
    L Roznovsky
    Department of Infectious Diseases, University Hospital Ostrava, Tr 17 listopadu 1790, 708 52 Ostrava, Czech Republic
    Infection 38:395-400. 2010
    ..However, whether this protection against carriage of hepatitis B virus is maintained into early adulthood is as yet unknown...
  79. ncbi Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120
    Farley Cleghorn
    Center for HIV AIDS, Constella Futures, Washington, DC, USA
    J Acquir Immune Defic Syndr 46:222-30. 2007
    ..vCP1452 was administered alone or with a heterologous boost of MN rgp120 glycoprotein. The trial was pivotal in deciding whether these vaccines advanced to phase 3 efficacy trials...
  80. ncbi Vaccination schedules to raise antibody concentrations against epsilon-toxin of Clostridium perfringens in ewes and their triplet lambs
    C de la Rosa
    Department of Animal Science, Cornell University, Ithaca, NY 14853 4801, USA
    J Anim Sci 75:2328-34. 1997
    ..Because concentrations of .2 IU/mL may be protective, these results indicate that vaccination of ewes before lambing imparts passive protection in lambs to 12 wk of age, whereas vaccination of young lambs provides no added protection...
  81. ncbi Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands
    Tjalke A Westra
    Department of Pharmacy, University of Groningen, The Netherlands
    Clin Ther 32:1479-95. 2010
    ..Because pertussis is most severe in unimmunized infants and infants who have only received some of the recommended doses, new pertussis immunization strategies should be considered to protect this vulnerable population...
  82. ncbi Effectiveness and net cost of reminder/recall for adolescent immunizations
    Christina A Suh
    Children s Outcomes Research Program, Children s Hospital Colorado, Aurora, Colorado 80045, USA
    Pediatrics 129:e1437-45. 2012
    ..To assess the effectiveness of reminder/recall (R/R) for immunizing adolescents in private pediatric practices and to describe the associated costs and revenues...
  83. ncbi DTP with or after measles vaccination is associated with increased in-hospital mortality in Guinea-Bissau
    Peter Aaby
    Projecto de Saude de Bandim, Apartado 861, Bissau, Guinea Bissau
    Vaccine 25:1265-9. 2007
    ..The sequence is not always respected. We examined in-hospital mortality of children having received DTP with or after measles vaccine...
  84. ncbi Hepatitis B Vaccine in national immunization schedule: a preventive step in India
    RAMESH VERMA
    Department of Community Medicine, Pt B D Sharma PGIMS, Rohtak Haryana, India
    Hum Vaccin 7:1387-8. 2011
    ..The current immunization schedule for hepatitis B vaccine includes a dose given as early as possible after birth, preferably within 24 hours ..
  85. ncbi Modifying the antigen-immunization schedule improves the variety of monoclonal antibodies obtained from immune-phage antibody libraries against HIV-1 Nef and Vif
    Mai Yoshikawa
    Department of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan
    J Biosci Bioeng 111:597-9. 2011
    ..Here we show that the immunization schedule affects the immune phage antibody library properties. We subcutaneously (s.c...
  86. ncbi Predictors of age-appropriate receipt of DTaP dose 4
    Tara W Strine
    Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Am J Prev Med 25:45-9. 2003
    In the United States, the national childhood immunization schedule calls for children to receive four doses of DTaP (diphtheria and tetanus toxoids and acellular pertussis) vaccine administered at 2, 4, 6, and 15 to 18 months...
  87. ncbi Minimum time interval adjustment for 4-3-1 immunization rates among two-year-old children
    R P Steiner
    Department of Family and Community Medicine, University of Louisville, Kentucky 40292, USA
    Am J Prev Med 16:189-94. 1999
    ....
  88. ncbi Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination
    Veronica Kolos
    University of Sydney, Australia
    Vaccine 25:588-90. 2007
    ..These data suggest that residence in a remote area, as a proxy for poorer living conditions for indigenous people, and delayed vaccination, both contribute to higher pertussis hospitalization rates in indigenous infants...
  89. ncbi Compliance with national immunization guidelines for children younger than 2 years, 1996-1999
    Loren K Mell
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Pediatrics 115:461-7. 2005
    ..To evaluate compliance with national immunization guidelines among a large cohort of children cared for at health maintenance organizations (HMOs) and to examine effects on immunization status...
  90. ncbi Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
    J J Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 19:1732-7. 2001
    ..These results suggest that baculovirus-expressed H5 HA can induce functional antibody in individuals who have not had prior exposure to H5 viruses, but that further studies to improve the immunogenicity of the vaccine are needed...
  91. ncbi Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule
    M Magdalena Gherardi
    Department of Molecular and Cellular Biology, Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas, Campus Universidad Autonoma, Madrid, Spain
    J Immunol 172:6209-20. 2004
    ..Our findings are of relevance in the area of vaccine development and support the optimization of protocols of immunization based on MVA as vaccine vectors to induce mucosal immune responses against HIV...
  92. ncbi Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States
    Ismael R Ortega-Sanchez
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 46:1-13. 2008
    ..The objective of our study was to analyze the cost-effectiveness of a catch-up vaccination campaign with quadrivalent meningococcal conjugate vaccine for children and adolescents aged 11-17 years...
  93. ncbi Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua
    Manish Patel
    Viral Gastroenteritis Section, MS A47, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA
    JAMA 301:2243-51. 2009
    ..Nicaragua introduced RV5 in 2006, providing the first opportunity to assess the association between vaccination and rotavirus disease in a developing country...
  94. ncbi When and why children fall behind with vaccinations: missed visits and missed opportunities at milestone ages
    Elizabeth T Luman
    National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia 30333, USA
    Am J Prev Med 36:105-11. 2009
    ....
  95. ncbi A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth
    Salvacion Gatchalian
    Research Institute for Tropical Medicine, Filinvest Corporate Centre, Alabang, Muntinlupa City, Manila, Philippines
    Hum Vaccin 1:198-203. 2005
    ..A birth dose of HBV is important to maximize protection against hepatitis B in endemic regions where the EPI schedule is in place...
  96. ncbi General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Andrew T Kroger
    Immunization Services Division, National Center for Immunization and Respiratory Diseases proposed, CDC, Atlanta, GA 30333, USA
    MMWR Recomm Rep 55:1-48. 2006
    ..cdc.gov/nip...
  97. ncbi Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses
    Arunee Sabchareon
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    Am J Trop Med Hyg 66:264-72. 2002
    ..All subjects seroconverted to serotype 3 after one dose. Serotype 4 elicited the lowest primary response but the highest increase in seroconversion after the second dose...
  98. ncbi Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales
    A Melegaro
    Modelling and Economics Unit, Health Protection Agency, Communicable Disease Surveillance Centre, 61 Colindale Avenue, London NW9 5EQ, UK
    Vaccine 22:4203-14. 2004
    ..To establish whether universal vaccination of infants with the pneumococcal conjugate vaccine is likely to be cost-effective from the perspective of the health care provider (NHS)...
  99. ncbi A review of the long-term protection after hepatitis A and B vaccination
    Pierre Van Damme
    Centre for the Evaluation of Vaccination, WHO Collaborating Centre for Prevention and Control of Viral Hepatitis, Department of Epidemiology and Social Medicine, University of Antwerp, Belgium
    Travel Med Infect Dis 5:79-84. 2007
    ....
  100. pmc Risk factors for delay in age-appropriate vaccination
    Kevin J Dombkowski
    Child Health Evaluation and Research CHEAR Unit, Division of General Pediatrics, University of Michigan, 300 N Ingalls, Rm 6C11, Ann Arbor, MI 48109 0456, USA
    Public Health Rep 119:144-55. 2004
    ....
  101. ncbi The relation of parent and provider characteristics to vaccination status of children in private practices and managed care organizations in Maryland
    N Hughart
    Department of Maternal and Child Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21205, USA
    Med Care 37:44-55. 1999
    ..This study sought to identify provider practices and policies in private pediatric settings that relate to vaccination status, controlling for the characteristics of the children served...

Research Grants68

  1. Development of a Recombinant Tetravalent Dengue Vaccine Based on a Subunit Envelo
    Lynda G Tussey; Fiscal Year: 2013
    ..While interference can be overcome by a 12-month immunization schedule, this schedule renders the vaccine unsuitable for recipients requiring rapid development of immunity...
  2. Novel Tetravalent Vaccines for Dengue Virus
    ROBERT GERALD WHALEN; Fiscal Year: 2013
    ..dengue vaccine in clinical testing is a complex mixture of four live-attenuated viruses that requires an immunization schedule covering 12 months to achieve full seroconversion...
  3. Coadministration of capsid modified adenovirus for malaria vaccine development
    Alberto Moreno; Fiscal Year: 2013
    ..The overall goal of this research proposal is to simplify the immunization schedule by reducing the need for boosting at regular intervals...
  4. Novel Engineering of a P. falciparum Merozoite Surface Protein 1 Malaria Vaccine
    GEORGE S HUI; Fiscal Year: 2010
    ..regimens to efficiently induce protective antibodies under the more favorable logistics of a reduced immunization schedule and the use of readily acceptable adjuvants...
  5. Lactoferrin as an Adjuvant for Cellular Immunity
    Jeffrey K Actor; Fiscal Year: 2010
    ..Areas that require further investigation concern (i) optimization of the immunization schedule for use of the adjuvant;and (ii) whether the production protocol developed for the initial expression of ..
  6. Influenza Immunization of Children in India
    Wayne M Sullender; Fiscal Year: 2013
    ..The temporal circulation of influenza in India suggests the current fall immunization schedule may not be optimal...
  7. Epitope-Targeted Vaccine for HIV-1 Prevention
    SUSAN B ZOLLA-PAZNER; Fiscal Year: 2011
    ..of envelope-based DNA primes and adjuvants for use with V3- scaffold immunogens, along with the best immunization schedule to induce broad, potent and long-lasting functional V3-specific Ab responses in rabbits...
  8. BioThrax Schedule Optimization for Post-Exposure Prophylaxis of Anthrax
    Robert Hopkins; Fiscal Year: 2006
    ..This phase 3b clinical trial, Safety, Immunogenicity, and Immunization Schedule Study of Post-Exposure Prophylaxis for BioThrax(r) in a Population of Healthy Adults, will evaluate the ..
  9. Production of neutralizing mAbs from HIV vaccinees
    Shixia Wang; Fiscal Year: 2013
    ..Specific Aim 5: To expand the production of Env-specific mAbs from additional vaccinees including PBMCs collected at different time points in the immunization schedule.
  10. A Randomized Trial of Vaccine Adherence in Young IDU
    Paula Lum; Fiscal Year: 2006
    ..none) in enhancing adherence to a multiple dose immunization schedule. We have three secondary objectives...
  11. Generation of antibodies by genetic immunization
    Hans Herweijer; Fiscal Year: 2002
    ..studies, we will further optimize genetic immunization methods by including cytokine genes, refining the immunization schedule, and testing different expression vectors and mouse strains...
  12. UTILIZATION OF IMMUNIZATION SVCS: PSYCHOSOCIAL APPROACH
    Hoda Atta; Fiscal Year: 1993
    ..Psychosocial factors to be examined in this subset include: knowledge about immunization schedule, vaccine availability, vaccine preventable disease, and health services that provide the vaccine; ..
  13. IMMUNOTHERAPY OF MELANOMA WITH ANTIIDIOTYPIC ANTIBODIES
    Soldano Ferrone; Fiscal Year: 1999
    ..The information resulting from studies in animal model systems will be utilized to design the immunization schedule with the most effective adjuvant and combination of anti-id mAb in patients with advanced melanoma in a ..
  14. DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION
    Richard Zimmerman; Fiscal Year: 2001
    ..This project will furnish relevant, up-to-date to enhance policy planning, practice management and medical education. ..
  15. IMMUNOGENETIC MECHANISMS OF VACCINE RESPONSE
    Gregory A Poland; Fiscal Year: 2010
    ..The knowledge gained from these studies will enable us to design new strategies and new vaccines to protect human health against viral diseases. ..
  16. THE EFFECTIVENESS OF VACCINES IN CLINICAL PRACTICE
    Eugene Shapiro; Fiscal Year: 2004
    ..Shapiro to review their progress and to help them develop their own studies as well as to develop strategies for the development of their careers. ..
  17. Effectiveness of Varicella Vaccine in Clinical Practice
    Eugene Shapiro; Fiscal Year: 2006
    ..abstract_text> ..
  18. Training in Patient-Oriented Research for Physicians
    Eugene Shapiro; Fiscal Year: 2006
    ..Ultimately, the Yale CRS Program will help to increase the pool of physician-investigators who will be uniquely poised to conduct research to directly improve the health of all Americans. [unreadable] [unreadable] [unreadable]..
  19. Role of DAP12 in type 1 anti-mycobacterial immunity
    Zhou Xing; Fiscal Year: 2005
    ..We strongly believe that our studies will provide new insights into the mechanisms of type 1 anti-microbial immunity and novel targets for immune modulation. ..
  20. The Role of a Novel Coronavirus In Kawasaki Disease
    Jeffrey Kahn; Fiscal Year: 2007
    ..We have identified a novel human virus, designated the New Haven coronavirus that is associated with KD. The goals of this study is to investigate the role of this novel virus in KD. [unreadable] [unreadable]..
  21. MACROPHAGE IRON METABOLISM AND TUBERCULOSIS INFECTION
    Megan Murray; Fiscal Year: 2007
    ..tuberculosis may help identify those at high risk for disease progression and lead to therapeutic interventions aimed at reducing macrophage iron stores. [unreadable] [unreadable]..
  22. 8th International Symposium - Saga of the Genus Bordetella, 1906-2006
    Erik Hewlett; Fiscal Year: 2006
    ..unreadable] The bordetella community is an especially open and collaborative[unreadable] collection of scientists and it is important to assure and support[unreadable] attendance of trainees at meetings such as this. ..
  23. T-Cell Responses Predict Influenza Risk in Older Adults
    Janet E McElhaney; Fiscal Year: 2010
    ..3) Test heat shock proteins (Hsp) as potential vaccine adjuvants to enhance the CTL response to vaccination. ..
  24. Molecular basis meningococcal group A capsular immunity
    Dan Granoff; Fiscal Year: 2007
    ..abstract_text> ..
  25. Second Generation Rabies Vaccines
    James McGettigan; Fiscal Year: 2007
    ..The development of treatment that relies on only one to two doses of vaccine instead of six inoculations will greatly enhance the effectiveness of rabies virus prevention. [unreadable] [unreadable] [unreadable]..
  26. Sustainable strategies for increasing CIS use among African American and Hispanic
    Matthew Kreuter; Fiscal Year: 2007
    ..Because the intervention is highly integrated within current CIS structure and practices, this approach can be readily adopted if research evidence establishes its effectiveness. [unreadable] [unreadable] [unreadable]..
  27. The Population-Based Effectiveness in Asthma and Lung Diseases (PEAL) Network
    Tracy A Lieu; Fiscal Year: 2010
    ..This project is innovative in that we will link claims, electronic medical record, patient, and provider data, and will build new linkages with a Medicaid plan to include vulnerable groups who are disproportionately burdened by asthma. ..
  28. Implementation of Asthma Guidelines in Primary Care; Comparison of 4 approaches
    James W Mold; Fiscal Year: 2010
    ..If effective, the same strategies could be used to facilitate implementation of other chronic disease guidelines. ..
  29. Regulation of murine neonatal Th2 function
    REBECCA D ADKINS; Fiscal Year: 2010
    ..This idea is supported by our findings that the function of peripheral CD4+ cells in neonates resembles that of RTE in adults. ..
  30. Optional Influenza Vaccine And Population Adherence
    Alison Galvani; Fiscal Year: 2009
    ....
  31. Internet Based Patient-Centered Asthma Management System
    Dimitri Christakis; Fiscal Year: 2009
    ..Children in AsthmaNet families will be more likely to report using written care plans. Aim 4: to decrease the number of symptom days for children with asthma H4. Children in AsthmaNet families will experience fewer symptom days. ..
  32. Minority Pre-doctoral Education to Reduce Disparities
    Matthew Kreuter; Fiscal Year: 2007
    ..The School of Public Health and Graduate School at Saint Louis University are strongly committed to this program, and have pledged 85% tuition scholarships for students involved. [unreadable] [unreadable]..
  33. Enhancing Prevention for Children in Diverse Populations
    Tracy Lieu; Fiscal Year: 2008
    ..Support from this K24 award will come at a critical time for Dr. Lieu and for the junior faculty in her new Center. [unreadable] [unreadable]..
  34. RECOMBINANT & LIVE ORAL SALMONELLA TYPHI HYBRID VACCINES
    Myron Levine; Fiscal Year: 2008
    ..abstract_text> ..
  35. Using MEPS Data to Inform Public-Plan Consumerism
    Matthew Davis; Fiscal Year: 2007
    ..Findings will have immediate relevance for implementation of the HOA projects and other consumerism efforts. [unreadable] [unreadable] [unreadable]..
  36. Measurement of Alcohol Use Among HIV-Positives in Uganda
    Judith Hahn; Fiscal Year: 2007
    ..This study will validate novel biomarkers and new and standard self-reported measures of alcohol use among HIV positives in Uganda. [unreadable] [unreadable] [unreadable] [unreadable]..
  37. Immunobiological Role of Fertilization Antigen(FA-1)
    RAJESH NAZ; Fiscal Year: 2007
    ..unreadable] [unreadable]..
  38. Polyvalent DNA Plus Protein HIV Vaccines
    Shan Lu; Fiscal Year: 2010
    ..This will allows us to effectively screen a large number of unique primary Env antigens to formulate the effective polyvalent HIV vaccines for the next phase of clinical testing. ..
  39. High throughput proteomic analysis of Salmonella enterica
    Edward Ryan; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable] [unreadable]..
  40. Multi-gene plague vaccine with expanded protection
    Shan Lu; Fiscal Year: 2004
    ..This project will employ the most advanced DNA immunization technology in combination with small-scale protein production to quickly develop potential subunit-based plague vaccine products. ..
  41. FRANCISELLA TULARENSIS: INNATE RESISTANCE TO IHALATION
    Stephen Gregory; Fiscal Year: 2004
    ..abstract_text> ..
  42. Application of IVIAT to Bacillus anthracis
    Edward Ryan; Fiscal Year: 2004
    ..IVIAT is an established protocol in our laboratory, and this preliminary collaborative study should lay a foundation for subsequent analysis of identified B. anthracis genes and their products. ..
  43. PREDICTING VACCINE STATUS & ED USE IN MEDICAID NEWBORNS
    Evaline Alessandrini; Fiscal Year: 2004
    ..The broad goals of the research project are to delineate factors that place poor children at risk for inadequate primary care health services and to identify these children so that effective interventions may be made. ..
  44. NIH D.C. INITIATIVE TO REDUCE INFANT MORTALITY
    Ayman El Mohandes; Fiscal Year: 2003
    ..The impact of the intervention on fathers and kinship and how they relate to the mother/infant dyad will also be analyzed. ..
  45. UNSTUDIED INFANTS: LOW RISK BABIES IN A HIGH RISK PLACE
    Marie McCormick; Fiscal Year: 2002
    ..Results will identify sites with better outcomes and the practices associated with them. These outcomes represent achievable goals well within the scope of current technology. ..
  46. DIETARY FATTY CONTROL OF INFLAMMATION
    Kevin High; Fiscal Year: 2002
    ..Health relateness: Answering these fundamental questions will shed critical light on the feasibility of utilizing dietary fatty acids to regulate AA metabolism and related clinical disorders. ..
  47. Chimeric Adenovirus Vaccine Vectors for HIV/SIV
    DAN BAROUCH; Fiscal Year: 2005
    ..Within the two-year time frame of this award, sufficient data will be generated with candidate chimeric rAd vaccines to justify further vaccine/challenge studies in rhesus monkeys. ..
  48. VOCABULARY MANAGEMENT FOR CLINICAL RESEARCH DATABASES
    Cynthia Brandt; Fiscal Year: 2005
    ....
  49. Genital Ulcer Disease and HIV Transmission
    Jeanne Sheffield; Fiscal Year: 2005
    ..The pursuit of these aims will further elucidate the cellular and molecular bases of the interrelationship between GUD and HIV-1 transmission, particularly in women. ..
  50. IT-Supported Early Treatment of Childhood Overweight
    William Adams; Fiscal Year: 2006
    ..abstract_text> ..
  51. Bacterial Vaccine Antigen Discovery
    LAWRENCE PAOLETTI; Fiscal Year: 2006
    ..Aim 2). Findings from these studies utilizing this unique approach to vaccine antigen discovery could be directly applied to other bacterial pathogens. ..
  52. CONTROL OF EPIDEMIC INFLUENZA
    PEDRO PIEDRA; Fiscal Year: 2007
    ..abstract_text> ..
  53. Clinical Performance Measures & Outcomes in Adolescents
    Susan Furth; Fiscal Year: 2005
    ..abstract_text> ..
  54. Decision Analysis of Otitis Media Vaccination Strategies
    Tracy Lieu; Fiscal Year: 2005
    ..The decision analytic model will yield information toward the optimal choices for current scientific inquiry, and will also provide a foundation for updated analyses as otitis media vaccines are further developed and tested. ..
  55. Communication, Perspectives, & Child Asthma Disparities
    Tracy Lieu; Fiscal Year: 2005
    ..This information is critical to the design of effective, culturally tailored interventions to eliminate disparities in health care for childhood asthma and other chronic diseases. ..
  56. Neisseria meningitidis antigens expressed in infection
    Dan Granoff; Fiscal Year: 2005
    ..meningitidis disease, including group B strains for which there is currently no vaccine available. Also, characterization of gene expression in an in vivo model will lead to a better understanding of meningococcal pathogenesis. ..
  57. AUTOLOGOUS HAPTEN MODIFIED VACCINE FOR HUMAN CANCER
    David Berd; Fiscal Year: 2001
    ..This work may lead to the development of reagents useful in identifying the target antigens. ..
  58. Functional Senescence of Innate Immunity and Pneumonia
    Kevin High; Fiscal Year: 2003
    ..These data are essential to design meaningful studies using the case-control method, the most effective means of studying the link between immune senescence and infection risk. ..
  59. VZV Receptors and Infective Mechanisms
    Anne Gershon; Fiscal Year: 2007
    ..It may also make it possible to develop a safer and more efficacious vaccine. ..
  60. An HB Vaccine Model For HIV Vaccine Trials in Drug Users
    Lu Yu Hwang; Fiscal Year: 2007
    ..abstract_text> ..
  61. CHEMOIMMUNOTHERAPY FOR BREAST CANCER TREATMENT
    Leisha Emens; Fiscal Year: 2006
    ..abstract_text> ..
  62. PEDIATRICS AIDS CLINICAL TRIALS GROUP
    Anne Gershon; Fiscal Year: 2006
    ..We have competent, outstanding staff whose aim is not only to provide compassionate medical care to HIV-infected patients but also to perform meaningful and useful research on prevention and treatment of HIV infection. ..
  63. Brucella, Aging and Role of IL-17 in Host Defense
    Kevin High; Fiscal Year: 2005
    ..The data generated in this proposal will form the foundation of future R01 proposals aimed at enhancing immunity vs. intracellular pathogens in our aging population. ..
  64. ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
    Paul Offit; Fiscal Year: 2005
    ..The availability of microencapsulated virus provides a unique opportunity to understand the relationship between APC and protective mucosal immune responses. ..
  65. Exploratory Center for Vaccinology Research (RMI)
    Walter Orenstein; Fiscal Year: 2007
    ..abstract_text> ..
  66. VACCINE EFFICACY IN CHILDREN WITH SICKLE CELL DISEASE
    Thomas Adamkiewicz; Fiscal Year: 2006
    ..abstract_text> ..
  67. Analyzing Vaccine Programs/Policies in Western Europe
    Gary Freed; Fiscal Year: 2004
    ..abstract_text> ..